| Literature DB >> 33993337 |
Ciro Esposito1, Lorenzo Masieri2, Thomas Blanc3, Thomas Lendvay4, Maria Escolino5.
Abstract
This study aimed to report a multi-institutional experience with robot-assisted laparoscopic surgery (RALS) for treatment of urinary tract stones in children. The medical records of 15 patients (12 boys), who underwent RALS for urolithiasis in 4 international centers of pediatric urology over a 5-year period, were retrospectively collected. The median patient age was 8.5 years (range 4-15). Eleven/fifteen patients (73.3%) had concurrent uretero-pelvic junction obstruction (UPJO) and 2/15 patients (13.3%) had neurogenic bladder. Stones were in the renal pelvis in 8/15 (53.3%), in the lower pole in 3/15 (20%), in the bladder in 2/15 (13.3%), and in multiple locations in 2/15 (13.3%). One patient (6.6%) had bilateral multiple kidney stones. The median stone size was 10.8 mm (range 2-30) in upper tract location and 27 mm (range 21-33) into the bladder. Eleven patients with concomitant UPJO underwent simultaneous robot-assisted pyelolithotomy and pyeloplasty in 12 kidney units. Two patients with isolated staghorn stones received robot-assisted pyelolithotomy. Robot-assisted cystolithotomy was performed in two patients with bladder stones. The median operative time was 131.8 min (range 60-240). The stone-free rate was 80% following initial surgery and 100% after secondary treatment. Clavien 2 complications (hematuria, infections) were recorded in 5/15 patients (33.3%). Three/fifteen patients (20%) with residual renal stones were successfully treated using ureterorenoscopy (Clavien 3b). RALS was a feasible, safe and effective treatment option for pediatric urolithiasis in selected cases such as large bladder stones, bilateral kidney stones, staghorn stones or concomitant anomalies such as UPJO requiring simultaneous pyeloplasty.Entities:
Keywords: Children; Lithotomy; Nephroscopy; Pyeloplasty; Robot; Stones
Mesh:
Year: 2021 PMID: 33993337 PMCID: PMC8560673 DOI: 10.1007/s00240-021-01271-5
Source DB: PubMed Journal: Urolithiasis ISSN: 2194-7228 Impact factor: 3.436
Fig. 1Patient (a) and ports (b) position in a simultaneous right pyelolithotomy and pyeloplasty
Fig. 2Operative steps of pyelolithotomy: the renal pelvis is opened and the stone is extracted using robotic graspers (a); the ureteroscope is introduced into the renal pelvis (b) and the residual fragments are removed under vision (c); a double J stent is inserted (d); the renal pelvis is closed using interrupted stitches (e); the stone is extracted (f)
Fig. 3Bilateral multiple kidney stones: KUB (a) and intra-operative view (b)
Fig. 4Large bladder stone: KUB (a); intra-operative view (b); ex vivo (c)
Patient demographics
| Demographics | ||
|---|---|---|
| Case number, | 15 | |
| Gender (male), | 12 (80%) | |
| Median age, years (range) | 8.5 (4–15) | |
| Median weight, kgs (range) | 32.2 (14–55) | |
| Associated anomalies | ||
| Uretero–pelvic junction obstruction (UPJO), | 11 (73%) | |
| Neurogenic bladder, | 2 (13.3%) | |
| Other, | 0 | |
| Presentation symptoms | ||
| Colicky flank pain, | 6 (40%) | |
| Colicky flank pain, hematuria, | 2 (13.3%) | |
| Urinary tract infections (UTIs), | 5 (33.3%) | |
| Asymptomatic, incidental finding, | 2 (13.3%) | |
| Stone location | ||
| Renal pelvis, | 8 (53.3%) | |
| Lower pole, | 3 (20%) | |
| Renal pelvis and lower pole, | 2 (13.3%) | |
| Bladder, | 2 (13.3%) | |
| Affected kidney data ( | ||
| Side | ||
| Left, | 4 (30.8%) | |
| Right, | 8 (61.5%) | |
| Bilateral, | 1 (7.7%) | |
| Total renal units, | 15 | |
| Location | ||
| Orthotopic, | 13 (100%) | |
| Pelvic, horseshoe, | 0 | |
| Stone pre-operative data | ||
| Median stone size, mm (range) | 20.8 (3–30) | |
| Median number of stones, | 3 (1–15) | |
| Multiple stones present, | 5 (35.7%) | |
| Indications for RALS | ||
| Concomitant pyeloplasty, | 11 (73.3%) | |
| Large stone size, | 7 (46.6%) | |
| Previous failed endourological procedure, | 1 (6.6%) | |
RALS robot-assisted laparoscopic surgery
Operative and postoperative data
| Operative and postoperative data | |
|---|---|
| Surgical procedure | |
| Anderson-hynes dismembered pyeloplasty + pyelolithotomy, | 11 |
| Pyelolithotomy, | 2 |
| Intra-operative nephroscopy, | 13 |
| Cystolithotomy, | 2 |
| Postoperative drainage | |
| Indwelling JJ stent, | 13 (86.7%) |
| Abdominal drain, | 6 (40%) |
| Indwelling bladder catheter, | 15 (100%) |
| Median duration of JJ stent, days (range) | 21 (18–31) |
| Median duration of bladder catheter after pyelolitothomy, days (range) | 2 (1–4) |
| Median duration of bladder catheter after bladder lithotomy, days (range) | 15.5 (10–21) |
| Median operative time, minutes (range) | 131.8 (60–240) |
| Intra-operative complications, | 0 |
| Conversion, | 0 |
| Median analgesic requirement, hours (range) | 24.5 (8–48) |
| Median hospital stay, days (range) | 2.8 (1–4) |
| Stone Composition | |
| Calcium oxalate, | 7 (46.7%) |
| Calcium phosphate, | 5 (33.3%) |
| Struvite, | 3 (20%) |
| Median follow-up length, months (range) | 23.2 (3–54) |
| Stone-free rate | |
| Following initial surgery, | 12 (80%) |
| Following secondary procedure, | 15 (100%) |
| Residual stone management | |
| Ureteroscopy, | 3 (20%) |
| Overall success rate of pyeloplasty | 11 (100%) |
| Degree of hydronephrosis at US | |
| Median pre-operative APD, mm (range) | 28.4 (18–40) |
| Median postoperative APD, mm (range) | 4.1 (0–8) |
| Renal drainage on Mag 3 renogram | |
| Before surgery, minutes (range) | 44 (27–78) |
| After surgery, minutes (range) | 7.7 (8–15) |
| Postoperative complications | |
| Hematuria, | 3 (20%)—II grade Clavien |
| Urinary tract infections (UTIs), | 2 (13.3%)—II grade Clavien |
| Residual stones, | 3 (20%)—IIIb grade Clavien |
| Stricture of ureteropelvic anastomosis, | 0 |
| Other, | 0 |
APD anterior–posterior pelvic diameter, US ultrasound